Diagnostic approach to primary immunodeficiency disorders

被引:0
作者
Manisha Madkaikar
A. Mishra
K. Ghosh
机构
[1] KEM Hospital,Department of Pediatric Immunology and Leukocyte Biology, National Institute of Immunohaematology (ICMR)
[2] KEM Hospital,National Institute of Immunohaematology
来源
Indian Pediatrics | 2013年 / 50卷
关键词
Antibody deficiency; Phagocytic defects; Immune dysregulation; Primary immunodeficiency disorders; Severe combined immunodeficiency (SCID);
D O I
暂无
中图分类号
学科分类号
摘要
Primary immunodeficiency disorders (PIDs) are a heterogeneous group of inherited disorders that affect different components of the immune system. There are more than 150 different disorders which have been described till date. Despite major advances in the molecular characterization of PIDs over the last 20 years, many patients remain undiagnosed or are diagnosed too late with severe consequences. Recognizing different clinical manifestations of PID is the first most important step. It should be followed by use of appropriate diagnostic tools from a vast number of investigations available. This review will focus on important presenting features of PID and laboratory approach for diagnosis of suspected cases of PID.
引用
收藏
页码:579 / 586
页数:7
相关论文
共 112 条
[21]  
Slatter MA(1992)Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS) J Clin Lab Immunol 38 143-131
[22]  
Gennery AR(2009)T cell subpopulation in paediatric healthy children: age-normal values J Allergy Clin Immunol 123 505-100
[23]  
Winkelstein JA(2006)Signal transducer and activator of transcription 5 tyrosine phosphorylation for the diagnosis and monitoring of patients with severe combined immunodeficiency Pediatr Blood Cancer 48 124-949
[24]  
Marino MC(2007)HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis Eur J Pediatr 166 95-undefined
[25]  
Ochs H(2010)Familial and acquired hemophagocytic lymphohistiocytosis J Allergy Clin Immunol 125 946-undefined
[26]  
Fuleihan R(undefined)Utilizing biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome undefined undefined undefined-undefined
[27]  
Scholl PR(undefined)undefined undefined undefined undefined-undefined
[28]  
Geha R(undefined)undefined undefined undefined undefined-undefined
[29]  
Berrington JE(undefined)undefined undefined undefined undefined-undefined
[30]  
Flood TJ(undefined)undefined undefined undefined undefined-undefined